ArticleInternational journal of cancer2026
Exposure to nitrosatable drugs during pregnancy and childhood cancer: A cohort study in Taiwan.
Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Nitrosatable drugs can contribute to the endogenous formation of N-nitroso compounds (NOCs) in humans. NOCs are carcinogenic in animal systems. However, the relationship between nitrosatable drug exposure in pregnancy and childhood cancer risk remains inconclusive. Using the Taiwan Maternal and Child Health Database (N = 2,090,806), we conducted a population-based cohort study of mother-child pairs with children born 2004-2015, to investigate the link between exposure to nitrosatable drugs in pregnancy and childhood cancer risk among offspring. Prescriptions of nitrosatable drugs were obtained from the National Health Insurance Program, and cancer cases were ascertained through linkage to the Cancer Registry. Cox proportional hazards regression models were applied to estimate both crude and adjusted hazard ratios (aHR) with 95% confidence intervals (CI). Among 3203 cancer cases, nitrosatable drug exposure was associated with higher risks of neuroblastoma (aHR = 1.27, 95% CI: 0.95-1.73) and hepatoblastoma (aHR = 1.49, 95% CI: 0.97-2.28). Neuroblastoma (aHR = 1.32, 95% CI: 0.96-1.82) and osteosarcoma (aHR = 2.05, 95% CI: 1.07-3.89) were most strongly associated with amides, while the risk of hepatoblastoma was highest among offspring of tertiary amine users (aHR = 1.57, 95% CI: 1.00-2.46), compared to other functional groups. Some results may need to be interpreted with caution due to the wide confidence intervals. Our findings highlight the need for future research into the biological mechanisms between NOCs and childhood cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.